Left untreated, sleep apnea can lead to a range of serious health problems, many of which disproportionately affect women: • ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Despite the range of possible symptoms and risk factors ... was higher in cases that were more severe, regardless of a person’s age. Sleep apnea can pose both short- and long-term risks that ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

including obstructive sleep apnea. OSA causes airway collapses during sleep and symptoms include snoring, fatigue and excessive daytime sleepiness. If left untreated, OSA can lead to serious ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide) as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with ...

Between 30-50% of adults with hypertension have OSA, and this number increases to between 70-80% in adults with resistant hypertension. Additionally, untreated moderate-to-severe OSA increases the ...

(MENAFN- EIN Presswire) diabetic patients with severe obstructive sleep apnea syndrome showed a 58% increase in all-cause mortality. Our research confirms that sleep-disordered breathing ...